TCR2 Therapeutics Inc.
TCRR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$152 | -$100 | -$67 | -$48 |
| Dep. & Amort. | $3 | $3 | $2 | $1 |
| Deferred Tax | -$0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $12 | $8 | $7 |
| Change in WC | $10 | $2 | $1 | -$1 |
| Other Non-Cash | $27 | $1 | -$1 | -$0 |
| Operating Cash Flow | -$101 | -$82 | -$57 | -$41 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | -$11 | -$7 | -$4 |
| Net Acquisitions | $15 | $0 | $8 | $4 |
| Inv. Purchases | -$268 | -$51 | -$153 | -$126 |
| Inv. Sales/Matur. | $194 | $141 | $111 | $110 |
| Other Inv. Act. | -$15 | -$0 | -$8 | -$4 |
| Investing Cash Flow | -$88 | $78 | -$49 | -$20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $131 | $134 | $79 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $132 | $135 | $80 |
| Financing Cash Flow | $0 | $132 | $135 | $80 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$190 | $129 | $29 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $224 | $95 | $66 | $48 |
| End Cash | $34 | $224 | $95 | $66 |
| Free Cash Flow | -$117 | -$93 | -$64 | -$45 |